ROCK1 and breast carcinoma: Rho/ROCK1 pathway inhibitor effectively alleviated the role of CNN1 in BRCA cell proliferation and invasion, indicating that miR-106b-5p could promote breast cancer cell cancerization by targeting CNN1 and Rho/ROCK1 pathway.